Catheter Ablation News and Research

RSS
Understanding more about heart rhythm disorders

Understanding more about heart rhythm disorders

National study sheds light on how to more effectively treat atrial fibrillation

National study sheds light on how to more effectively treat atrial fibrillation

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Common diabetes medication identified as a possible treatment for atrial fibrillation

Common diabetes medication identified as a possible treatment for atrial fibrillation

New OCTARAY™ Mapping Catheter with TRUEref™ Technology from Biosense Webster

New OCTARAY™ Mapping Catheter with TRUEref™ Technology from Biosense Webster

Simplicity is key when it comes to ablation, global AFib study finds

Simplicity is key when it comes to ablation, global AFib study finds

New system produces a 3D interactive map of arrhythmia hotspots in the heart

New system produces a 3D interactive map of arrhythmia hotspots in the heart

Radiation therapy for ventricular tachycardia may revert heart muscle cells to a younger state

Radiation therapy for ventricular tachycardia may revert heart muscle cells to a younger state

Study could help improve care for irregular heartbeats in patients with hypertrophic cardiomyopathy

Study could help improve care for irregular heartbeats in patients with hypertrophic cardiomyopathy

Type of heart failure may influence which approach is optimal for patients with AFib

Type of heart failure may influence which approach is optimal for patients with AFib

New AI predicts the location of “accessory pathways” in the heart

New AI predicts the location of “accessory pathways” in the heart

Scientists use ultrasound to map arrhythmic sites more accurately

Scientists use ultrasound to map arrhythmic sites more accurately

Understanding stroke and heart disease in women remains a major research priority

Understanding stroke and heart disease in women remains a major research priority

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

GlobalData: COVID-19 will have negative impact on elective cardiovascular procedures in Australia

GlobalData: COVID-19 will have negative impact on elective cardiovascular procedures in Australia

Researchers use ultrasound technique to accurately localize cardiac arrhythmias

Researchers use ultrasound technique to accurately localize cardiac arrhythmias

Mayo research provides evidence supporting benefit of ablation for heart failure patients with AFib

Mayo research provides evidence supporting benefit of ablation for heart failure patients with AFib

EHRA 2020: Latest practice-changing research in heart rhythm disorders

EHRA 2020: Latest practice-changing research in heart rhythm disorders

First patient in U.S. treated for atrial fibrillation using new type of ablation technology

First patient in U.S. treated for atrial fibrillation using new type of ablation technology

Researchers show why corrective surgery is not always beneficial for irregular heartbeat

Researchers show why corrective surgery is not always beneficial for irregular heartbeat

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.